Medical Device News Magazine

Global Brain Monitoring Market to Reach $9.94 Billion in 2028

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The “Brain Monitoring Market By Product Type, By End Use, By Application, and By Region” report has been added to’s offering.

The global brain monitoring market size is expected to reach USD 9,942.6 Million in 2028 and register a revenue CAGR of 5.9% over the forecast period, according to the latest report. The rising number of brain disorders, favorable government regulations regarding the adoption of brain monitoring devices, and technological advancements are some of the notable factors projected to fuel market growth over the forecast period.

In recent years, there has been a significant rise in the prevalence of brain disorders worldwide. According to the National Institute of Mental Health (NIMH), in the United States, approximately one in every five adults suffers from a mental illness. The global prevalence of Alzheimer’s disease is projected to reach 131.5 million by 2050. Moreover, the increasing geriatric population and the rising awareness about brain disorders are other major factors that are expected to drive market growth over the forecast period.

The favorable government regulations regarding the adoption of brain monitoring devices are expected to propel market growth over the forecast period. For instance, in February 2019, the U.S. Food and Drug Administration (FDA) cleared the RNS System for treating epilepsy.

The system is a brain-responsive neurostimulation device that helps in reducing seizure frequency by delivering targeted electrical stimulations to specific areas of the brain that are associated with seizure onset. Similarly, in January 2019, the FDA cleared the Intellis platform for treating chronic pain. The system is a spinal cord stimulator that helps in reducing pain by delivering electrical stimulations to specific areas of the spinal cord.

The increasing adoption of brain monitoring devices is expected to fuel market growth over the forecast period. For instance, in September 2019, researchers at the University of Glasgow developed a brain-computer interface (BCI) system that can be used to type at eight words per minute.

The system uses a non-invasive electroencephalography (EEG) headset to record brain activity and translate it into text. Similarly, in August 2019, a team of researchers at the University of Minnesota developed a non-invasive brain-computer interface (BCI) system that can be used to control robotic limbs. The system uses alternating current stimulation (ACS) to modulate the activity of neurons and generate signals that can be decoded by a computer to control robotic limbs.

Product Type Outlook (Revenue, USD Million; 2018-2028)

  • Electroencephalography (EEG) Devices
  • Magnetoencephalography (MEG) Devices
  • Transcranial Doppler (TCD) Devices
  • Intracranial Pressure (ICP) Monitors
  • Cerebral Oximeters
  • Magnetic Resonance Imaging (MRI) Devices
  • Computerized Tomography (CT) Devices
  • Positron Emission Tomography (PET) Devices
  • Electromyography Devices
  • Sleep Monitoring Devices

End Use Outlook (Revenue, USD Million; 2018-2028)

  • Hospitals
  • Neurology Centers
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others

Application Outlook (Revenue, USD Million; 2018-2028)

  • Parkinson’s Disease
  • Traumatic Brain Injury
  • Epilepsy
  • Dementia
  • Huntington’s Disease
  • Sleep Disorders
  • Stroke
  • Headache Disorders

Regional Outlook (Revenue, USD Million; 2018-2028)

Market Dynamics

Market drivers

  • Growing incidences of neurological disorders
  • Increasing prevalence of traumatic brain injuries
  • Technological Advancement in brain monitoring devices

Market restraints analysis

  • High cost of brain monitoring procedure and devices
  • Strict government rules for approval of devices

Key Topics Covered:

Chapter 1. Market Synopsis

Chapter 2. Executive Summary

Chapter 3. Indicative Metrics

Chapter 4. Brain Monitoring Market Segmentation & Impact Analysis

Chapter 5. Brain Monitoring Market By Product Type Insights & Trends

Chapter 6. Brain Monitoring Market By End Use Insights & Trends

Chapter 7. Brain Monitoring Market Application Insights & Trends

Chapter 8. Brain Monitoring Market Regional Outlook

Chapter 9. Competitive Landscape

Chapter 10. Company Profiles

 Companies Mentioned

  • Advanced Brain Monitoring Inc.
  • CAS Medical Systems Inc.
  • Compumedics Ltd.
  • Electrical Geodesics Inc.
  • General Electric Company (GE Healthcare)
  • Koninklijke Philips N.V. (Philips Healthcare)
  • Medtronic PLC.
  • Natus Medical Incorporated
  • Neural Analytics Inc
  • Nihon Kohden Corporation
  • Siemens Healthineers AG

For more information about this report visit here.

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.